[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352605-105":59,"doc-detail-352605-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","a-novel-approach-of-intraneural-facilitation-versus-standard-physical-therapy-for-the-prevention-of-chemotherapy-induced-peripheral-neuropathy-a-randomized-controlled-trial","A Novel Approach of Intraneural Facilitation Versus Standard Physical Therapy for the Prevention of Chemotherapy-Induced Peripheral Neuropathy - A Randomized Controlled Trial","","A randomized controlled trial compared Intraneural Facilitation (INF®) therapy and standard physical therapy (PT) for preventing chemotherapy-induced peripheral neuropathy (CIPN) in women with newly diagnosed breast and gynecologic cancer. Thirty-eight participants receiving platinum and/or taxane chemotherapy were assigned to INF® (n=20) or PT (n=18); sessions lasted 45 minutes twice weekly for 6 weeks. Neuropathy severity was assessed at baseline, 3 and 6 weeks, and 3 months post-intervention using the Pain Quality Assessment Scale. Adverse events were not reported. INF® showed significant numbness changes after week 6, while PT showed improvements across numbness, tingling, cramping, and pain measures between weeks 3 and 6. Nearly 80% completed chemotherapy cycles, with high satisfaction and low treatment burden, supporting feasibility, adherence, outcomes, and quality of life.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-novel-approach-of-intraneural-facilitation-versus-standard-physical-therapy-for-the-prevention-of-chemotherapy-induced-peripheral-neuropathy-a-randomized-controlled-trial/352605/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-novel-approach-of-intraneural-facilitation-versus-standard-physical-therapy-for-the-prevention-of-chemotherapy-induced-peripheral-neuropathy-a-randomized-controlled-trial/352605.png","ImageObject",300,407,{"name":92,"@type":93},"Jake","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was compared in this study to prevent CIPN?","Question",{"text":112,"@type":113},"Intraneural Facilitation (INF®) therapy was compared with standard physical therapy (PT) to prevent chemotherapy-induced peripheral neuropathy (CIPN) in women with newly diagnosed breast and gynecologic cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were participants assigned and what was the treatment schedule?",{"text":117,"@type":113},"Thirty-eight women receiving platinum and/or taxane chemotherapy were randomized to INF® (n=20) or PT (n=18). Both interventions lasted 45 minutes, twice weekly, for 6 weeks.",{"name":119,"@type":110,"acceptedAnswer":120},"What outcomes and safety results were reported?",{"text":121,"@type":113},"Neuropathy severity was evaluated at baseline, 3 weeks, 6 weeks, and 3 months post-intervention. No adverse events were reported, and both arms showed improvements in neuropathy-related symptoms with high acceptability and satisfaction.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352605,1790200281,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962084928904,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","A Novel Approach of Intraneural Facilitation Versus Standard Physical Therapy for the Prevention of Chemotherapy-Induced Peripheral Neuropathy: A Randomized Controlled Trial  \nJamie Hankins, PhD, RN, PHN 1, Mark Bussell, DPT, OCS 1,  \nIntegrative Cancer Therapies Volume 25: 1–18 © The Author(s) 2026 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/15347354251413222](DOI: 10.1177/15347354251413222)[ ](DOI: 10.1177/15347354251413222)[journals.sagepub.com/home/ict](journals.sagepub.com/home/ict)  \nLida Gharibvand, MS, PhD2, Won Jin Jeon, MD3, Dani Ran Castillo, MD3, Ellen D’Errico, PhD, RN4, and Gayathri Nagaraj, MD3  \nAbstract  \nThis study compared Intraneural Facilitation (INF® ) therapy and standard physical therapy (PT) in preventing chemotherapyinduced peripheral neuropathy (CIPN) in women with newly diagnosed breast and gynecologic cancer. Thirty-eight women undergoing platinum and/or taxane-based chemotherapy, without prior peripheral neuropathy, were randomized into INF® therapy (n = 20) and PT (n = 18). Treatments lasted 45 minutes, twice weekly, for 6 weeks. Neuropathy severity was evaluated using the Pain Quality Assessment Scale. Assessments were at baseline, 3 weeks, 6 weeks, and 3 months post-intervention. Acceptability, burden, and satisfaction were evaluated after 6 weeks. Among 38 patients, 12 (32%) experienced CIPN, with mean pain scores remaining mild ( ≤3) and no pharmacotherapy required until week 6. No adverse events were reported from the interventions. The INF® therapy arm showed significant changes in numbness (F = 6.030, P = .001, partial η2 = 0.262) after week 6, while the PT arm showed significant changes in numbness (Z = −2.39, P = .017), tingling (Z = −2.84, P = .004), cramping (Z = −2.120, P = .034), surface pain (Z = −2.75, P = .006), and deep pain (Z = −1.99, P = .046) between weeks 3 and 6. Nearly 80% of patients completed chemotherapy cycles with an average relative dose intensity of 90.4%(INF® therapy: 87.73% vs PT: 73.44%). Ninety-four percent of patients were satisfied with their care, accepted the treatments, and perceived them as a low burden. The results demonstrated that INF® therapy and PT are feasible options for CIPN, improving treatment adherence, outcomes, and quality of life for women with newly diagnosed breast and gynecological cancers.  \nTrial Registration-The study was pre-registered [on ClinicalTrials.gov](on ClinicalTrials.gov) (NCT03272919). August 8, 2017.  \nKeywords  \nchemotherapy-induced peripheral neuropathy, intraneural facilitation therapy, prevention, breast cancer, quality of life  \nReceived: July 16, 2025; accepted: December 18, 2025  \nIntroduction  \nChemotherapy-induced peripheral neuropathy (CIPN) remains a significant challenge, compromising chemotherapy (CT) treatment and the quality of life of patients with active cancer and cancer survivors.1-6 It occurs from the dose-dependent and cumulative effects of certain commonly used CT agents,4 affecting 30% to 60% of patients, up to 80% of those treated with taxanes,5,7-9 and about 47% of women treated for breast cancer 6 years post-treatment.10  \n1 Loma Linda University Health, Loma Linda, CA, USA  \n2Loma Linda University School of Allied Health Professions, Loma Linda, CA, USA  \n3Loma Linda University School of Medicine, Loma Linda, CA, USA 4Loma Linda University School of Nursing, Loma Linda, CA, USA  \nCorresponding Author:  \nJamie Hankins, Loma Linda University Health, Neuropathic Therapy Center, 25455 Barton Road Suite 208A, Loma Linda, CA 92354, USA.  \nEmail: [jamiejhankins@gmail.com](jamiejhankins@gmail.com)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons AttributionNonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use, reproduction and distributio","cbCaitL0lZRPIC4L","https://ap.wps.com/l/cbCaitL0lZRPIC4L","pdf",1700637,18,"English","# Abstract\n## Introduction","[{\"question\":\"What was compared in this study to prevent CIPN?\",\"answer\":\"Intraneural Facilitation (INF®) therapy was compared with standard physical therapy (PT) to prevent chemotherapy-induced peripheral neuropathy (CIPN) in women with newly diagnosed breast and gynecologic cancer.\"},{\"question\":\"How were participants assigned and what was the treatment schedule?\",\"answer\":\"Thirty-eight women receiving platinum and/or taxane chemotherapy were randomized to INF® (n=20) or PT (n=18). Both interventions lasted 45 minutes, twice weekly, for 6 weeks.\"},{\"question\":\"What outcomes and safety results were reported?\",\"answer\":\"Neuropathy severity was evaluated at baseline, 3 weeks, 6 weeks, and 3 months post-intervention. No adverse events were reported, and both arms showed improvements in neuropathy-related symptoms with high acceptability and satisfaction.\"}]","A Novel Approach of Intraneural Facilitation Versus Standard Physical Therapy for the Prevention of Chemotherapy-Induced Peripheral Neuropathy - A Randomized Controlled Trial | PDF",1790100439,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/370653e6080df01b02210817af4e3997.webp",983,1276,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9ae2d8a59e5ec68cd67cd3014ac90293.webp",982,1275,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/70a298184c55ccea99b00247b7ed32c8.webp",981,1273,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/642f91d4fe88ba20bc12d5c5401d0b22.webp",980,1272]